Audit 385506

FY End
2025-06-30
Total Expended
$87.82M
Findings
4
Programs
46
Year: 2025 Accepted: 2026-02-04

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1172403 2025-001 Material Weakness Yes C
1172404 2025-001 Material Weakness Yes C
1172405 2025-001 Material Weakness Yes C
1172406 2025-001 Material Weakness Yes C

Programs

ALN Program Spent Major Findings
12.RD 11268 A III IDIQ $41.53M Yes 1
12.RD 11236 MATRIX $12.42M Yes 1
12.800 P-100460 $7.78M Yes 0
12.615 11186 APEX $6.48M Yes 1
12.RD P-100324 $6.42M Yes 0
12.RD P-202470 $2.13M Yes 0
12.RD 11295 - OnRamp Hub: OY1-2 $1.48M Yes 1
43.008 P-402090 $1.14M Yes 0
12.RD 11205 F0002-F0004- Option 1 $962,908 Yes 0
12.RD 11255 IN THE MOMENT $918,966 Yes 0
12.RD 11221 ASTRA-IST $916,509 Yes 0
12.U01 11261 OnRamp Hub: Ohio $821,616 Yes 0
12.RD 11245 STAT $611,656 Yes 0
12.RD 11243 Connected Alliance $458,914 Yes 0
43.RD P-140200 $432,767 Yes 0
11.617 CONGRESSIONALLY-IDENTIFIED PROJECTS $423,591 Yes 0
43.RD P-520107 $367,601 Yes 0
43.009 P-140100 $362,194 Yes 0
43.RD P-520110 $269,444 Yes 0
43.RD P-520049 $262,612 Yes 0
43.008 P-402080 $255,863 Yes 0
43.RD P-520156 $245,065 Yes 0
43.RD P-520062 $217,693 Yes 0
81.087 RENEWABLE ENERGY RESEARCH AND DEVELOPMENT $152,667 Yes 0
12.RD 11270 Vertx $125,040 Yes 0
59.058 FEDERAL AND STATE TECHNOLOGY PARTNERSHIP PROGRAM $124,485 Yes 0
12.RD 11250 STEM Outreach $110,452 Yes 0
43.002 P-420113 $80,595 Yes 0
11.024 BUILD TO SCALE $64,059 Yes 0
12.RD 11273 Data Abyss - UMD $50,743 Yes 0
43.001 P-370044 $43,731 Yes 0
12.RD 11248 GEOCOG $34,809 Yes 0
43.001 P-402085 $27,429 Yes 0
11.112 MARKET DEVELOPMENT COOPERATOR PROGRAM $24,106 Yes 0
12.RD P-100612 $20,478 Yes 0
12.600 Federal and State Technology Partnership Program $11,138 Yes 0
12.RD P-100458 $11,094 Yes 0
12.RD 11240 HERMIONE II $10,753 Yes 0
43.001 P-370046 $7,909 Yes 0
43.RD P-520048 $7,311 Yes 0
47.084 NSF TECHNOLOGY, INNOVATION, AND PARTNERSHIPS $6,309 Yes 0
43.001 P-370047 $4,822 Yes 0
12.RD P-100456 $3,935 Yes 0
12.RD P-100455 $1,205 Yes 0
43.RD P-100500 $-551 Yes 0
12.RD 11076 HMT $-1,699 Yes 0

Contacts

Name Title Type
EHEEAGYKUB87 Chris Hovecar Auditee
4409623017 Jenifer Anderson Auditor
No contacts on file

Notes to SEFA

Basis of Presentation: Parallax Advanced Research Corporation and Affiliate (collectively, the Organization) prepares its consolidated financial information in accordance with accounting principles generally accepted in the United States of America (US GAAP). All intercompany accounts and transactions have been eliminated in consolidation for the Schedule of Expenditures and Federal Awards for the year ended June 30, 2025 unless otherwise stated. The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") includes the federal grant activities of Parallax Advanced Research Corporation and its affiliate under programs funded by the federal government for the year ended June 30, 2025. The Schedule has been prepared on the accrual basis in accordance with US GAAP and includes all federal awards and contracts entered into directly between the Organization and agencies and departments of the federal government, as well as funds passed through to the Organization by other recipients, and is in accordance with Uniform Guidance U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards ("Uniform Guidance"). Negative amounts reported on the Schedule are adjustments or credits made in the normal course of business to amounts reported as expenditures in prior fiscal years. Because the Schedule presents only a selected portion of the Organization's operations, it is not intended to and does not present its financial position, changes in net assets, or cash flows. Research and Development Cluster (“R&D cluster”): OMB Uniform Guidance defines research and development as follows: research is a systematic study directed toward fuller scientific knowledge or understanding of the subject studied: development is the systematic use of knowledge and understanding gained from research directed toward the production of useful materials, devices, systems, or methods, including design and development of prototypes and processes. The Organization’s work is closely aligned with the R&D cluster of programs in accordance with 2 CFR 200.17 and 2 CFR 200.87. Accordingly, the schedule of expenditures of federal awards reports all reportable programs in the R&D cluster. Subrecipient: Certain funds are passed through to subgrantee organizations by the Organization. Expenditures incurred by the subgrantees and reimbursed by the Organization are presented in the Schedule. The Organization is also the subrecipient of funds, which have been reported as expenditures and listed as pass-through funds.
Expenditures consist of direct and indirect costs. Direct costs are those that can be identified specifically with a project. Indirect costs are costs of services and resources that benefit both sponsored and non-sponsored projects but are necessary for the operation of the Organization. Expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. The Organization uses indirect cost rates to charge indirect costs to individual projects. The rates are the result of a number of complex cost allocation procedures that the Organization uses to allocate its indirect costs to both sponsored and non-sponsored activities. These indirect rates are reviewed and approved by the applicable cognizant agencies for the funds.
Due to the nature of research and development that the Organization performs on behalf of the federal government, various contracts and project information is considered classified, which includes “Top Secret,” “Secret,” or “Confidential.” As a result, the Schedule reflects summarized data by agency in order to properly safeguard various information as required by the federal government.

Finding Details

Federal Agency: U.S. Department of Defense. Federal Program: Research and Development Cluster. AL Number: ALN: 12.615 and 12.RD. Pass-through: Not applicable. Award Number: FA8650-19-3-9341/FA8650-19-3-9342, FA8650-22-D-6401, 47QFCA22F0043, and one classified contract. Award Year: Various. Type of Finding: Significant Deficiency and Noncompliance. Criteria: For cost-reimbursement contracts under the Federal Acquisition Regulations (FAR), 52.216-7(b)(1), with relation to supplies and services purchased for use on the contract, “ordinary course of business” would be in accordance with the terms and conditions of a subcontract or invoice, and ordinarily within 30 days of the request to the federal government for reimbursement. Condition: The Organization, specifically the entity Parallax Advanced Research (“Parallax”), did not have adequate documentation of extended payment terms in the ordinary course of business, and exceeded the typical 30 days. Context: It was noted that the Organization requested reimbursement from the federal agency for seven expenditures; however, the subsequent payment to the vendor for those expenditures was not made either within 30 days of the requested reimbursement or within the time period agreed-upon by the vendor. We did observe that payment was made within 30 days of receipt of the cash from the federal agency for six of the seven expenditures. Of those six expenditures, payments to vendors were made within two weeks of the required date, as described above, for five of them, indicating that they were included in the next pay run. Cause: Parallax has been extending terms and conditions of payments of vendors beyond 30 days from the date of reimbursement request, as necessary for overall operations and its cash management needs. Additionally, Parallax has also experienced timing challenges pertaining to cash collections. Effect: Subset of vendors were paid later than either 30 days from the date of the request for reimbursement from the government or the date that was agreed upon by the vendor. Questioned costs: None. Identification of how questioned costs were computed: Not applicable. Repeat finding: 2024-001. Recommendation: The Organization should review its procedures and update as necessary. Views of responsible officials: The Organization will consider the observation and the risks associated to determine action plan to address the finding. See corrective action plan.